Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysis

Daniel Martin Simadibrata, Bashar Adi Wahyu Pandhita, Muammar Emir Ananta, Tamara Tango
doi: https://doi.org/10.1101/2020.08.21.20166355

Article usage

Article usage: August 2020 to September 2024

AbstractFullPdf
Aug 20206080130
Sep 2020251095
Oct 2020132088
Nov 2020154092
Dec 2020105088
Jan 2021184061
Feb 2021112134
Mar 20211091044
Apr 2021129338
May 2021137273
Jun 2021118945
Jul 202195532
Aug 202188634
Sep 202193663
Oct 202180445
Nov 202169220
Dec 202172242
Jan 202264119
Feb 2022100214
Mar 202237511
Apr 202228316
May 202238420
Jun 202227310
Jul 20223335
Aug 202242512
Sep 202236716
Oct 202232619
Nov 20222934
Dec 2022241010
Jan 202333114
Feb 2023201010
Mar 202314720
Apr 202327315
May 202317118
Jun 202316710
Jul 2023624
Aug 202320229
Sep 202320415
Oct 202318612
Nov 20231785
Dec 202313111
Jan 202413510
Feb 202413115
Mar 202420319
Apr 20241559
May 2024956
Jun 20241559
Jul 20241426
Aug 20241069
Sep 20241525
Back to top
Posted August 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysis
Daniel Martin Simadibrata, Bashar Adi Wahyu Pandhita, Muammar Emir Ananta, Tamara Tango
medRxiv 2020.08.21.20166355; doi: https://doi.org/10.1101/2020.08.21.20166355
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area